US 11559515
Indole compounds and analogues thereof
granted A61KA61K31/416A61P
Quick answer
US patent 11559515 (Indole compounds and analogues thereof) held by BioCryst Pharmaceuticals, Inc. expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/416, A61P, A61P13/00, A61P13/10